The Raulet Laboratory at University-CA Berkeley is a leading research facility dedicated to investigating the mechanisms of recognition and killing of cancer cells and infected cells by natural killer (NK) cells and cytotoxic T cells. Their groundbreaking research aims to improve existing immunotherapies for cancer and design new ones by harnessing the findings on NK cell recognition, activation, and inhibition. The laboratory has made significant contributions to the field, including the development of therapy combinations that super-activate NK cells while preventing desensitization and inhibition, showing promise as new therapies for refractory cancers.
With a team of dedicated lab members and collaborations with other research groups, the Raulet Laboratory has published numerous scientific papers in prestigious journals such as Science Immunology, PNAS, and Nature Reviews Immunology. Their research findings have shed light on the roles of natural killer cells in immunity to cancer and have identified potential targets for immunotherapy. The laboratory also actively engages in training and mentoring graduate students and postdoctoral fellows, contributing to the advancement of scientific knowledge in the field of immunology.
Generated from the website